Loading…

Cortical Thickness of the Femur and Long‐Term Bisphosphonate Use

ABSTRACT Femoral cortical thickening has been mentioned in reports of atypical subtrochanteric/femoral shaft (ST/FS) fractures, which are associated with long‐term bisphosphonate (BP) use. However, whether thickening precedes BP use or results from BP use, as well as the role BPs may play in cortica...

Full description

Saved in:
Bibliographic Details
Published in:Journal of bone and mineral research 2015-02, Vol.30 (2), p.225-231
Main Authors: Niimi, Rui, Kono, Toshibumi, Nishihara, Atsushi, Hasegawa, Masahiro, Matsumine, Akihiko, Kono, Toshihiko, Sudo, Akihiro
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4875-3e7ee03831e4ebd036f959ca911587c8363ec11df8e0b1dbaafff69d67e8ba23
cites cdi_FETCH-LOGICAL-c4875-3e7ee03831e4ebd036f959ca911587c8363ec11df8e0b1dbaafff69d67e8ba23
container_end_page 231
container_issue 2
container_start_page 225
container_title Journal of bone and mineral research
container_volume 30
creator Niimi, Rui
Kono, Toshibumi
Nishihara, Atsushi
Hasegawa, Masahiro
Matsumine, Akihiko
Kono, Toshihiko
Sudo, Akihiro
description ABSTRACT Femoral cortical thickening has been mentioned in reports of atypical subtrochanteric/femoral shaft (ST/FS) fractures, which are associated with long‐term bisphosphonate (BP) use. However, whether thickening precedes BP use or results from BP use, as well as the role BPs may play in cortical thickening remain unclear. The purpose of this study was to investigate the relationship between cortical thickness and BP use. We enrolled 142 patients (mean age 79 years) who had taken BPs for more than 5 years, and enrolled 426 osteoporosis patients who had not used BPs as controls. We performed a case‐control study of patients with long‐term BP use and controls matched for age, sex, and levels of activities of daily living (ADLs) (1:3 ratio). On femoral radiographs, we measured femoral cortical thickness in three regions: 5 cm and 12.5 cm below the lesser trochanter and in the region of maximal cortical thickness. We compared cortical thicknesses between patients taking BP and controls and evaluated longitudinal changes in cortical thickness. There were no significant differences in cortical thickness between long‐term BP users and controls. In addition, after further use of BP for a minimum of 1 year, we observed no significant differences in the changes in cortical thickness at any level of the femur. In conclusion, our study did not find evidence of cortical thickening at the ST/FS area of the femur with long‐term BP use. © 2014 American Society for Bone and Mineral Research.
doi_str_mv 10.1002/jbmr.2345
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1808650595</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1652461936</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4875-3e7ee03831e4ebd036f959ca911587c8363ec11df8e0b1dbaafff69d67e8ba23</originalsourceid><addsrcrecordid>eNqF0b1OwzAUBWALgWgpDLwAssQCQ1o7jh1npBXlR0VIKMyRk1zTlCQudiPUjUfgGXkSEloYkBCDdZdP5-r6IHRMyZAS4o8WaWWHPgv4DupT7jMvEJLuoj6RMvBIwGgPHTi3IIQILsQ-6vmccuEL2kfjibGrIlMljudF9lyDc9hovJoDnkLVWKzqHM9M_fTx9h6DrfC4cMu56V6tVoAfHRyiPa1KB0fbOUDx9DKeXHuz-6ubycXMywIZco9BCECYZBQCSHPChI54lKmIUi7DTDLBIKM01xJISvNUKa21iHIRgkyVzwbobBO7tOalAbdKqsJlUJaqBtO4hEoiBSc84v9Twf1A0KhdOUCnv-jCNLZu72hVEPqR5FK26nyjMmucs6CTpS0qZdcJJUlXQdJVkHQVtPZkm9ikFeQ_8vvPWzDagNeihPXfScnt-O7hK_ITlDqP1g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1647298588</pqid></control><display><type>article</type><title>Cortical Thickness of the Femur and Long‐Term Bisphosphonate Use</title><source>Oxford Journals Online</source><creator>Niimi, Rui ; Kono, Toshibumi ; Nishihara, Atsushi ; Hasegawa, Masahiro ; Matsumine, Akihiko ; Kono, Toshihiko ; Sudo, Akihiro</creator><creatorcontrib>Niimi, Rui ; Kono, Toshibumi ; Nishihara, Atsushi ; Hasegawa, Masahiro ; Matsumine, Akihiko ; Kono, Toshihiko ; Sudo, Akihiro</creatorcontrib><description>ABSTRACT Femoral cortical thickening has been mentioned in reports of atypical subtrochanteric/femoral shaft (ST/FS) fractures, which are associated with long‐term bisphosphonate (BP) use. However, whether thickening precedes BP use or results from BP use, as well as the role BPs may play in cortical thickening remain unclear. The purpose of this study was to investigate the relationship between cortical thickness and BP use. We enrolled 142 patients (mean age 79 years) who had taken BPs for more than 5 years, and enrolled 426 osteoporosis patients who had not used BPs as controls. We performed a case‐control study of patients with long‐term BP use and controls matched for age, sex, and levels of activities of daily living (ADLs) (1:3 ratio). On femoral radiographs, we measured femoral cortical thickness in three regions: 5 cm and 12.5 cm below the lesser trochanter and in the region of maximal cortical thickness. We compared cortical thicknesses between patients taking BP and controls and evaluated longitudinal changes in cortical thickness. There were no significant differences in cortical thickness between long‐term BP users and controls. In addition, after further use of BP for a minimum of 1 year, we observed no significant differences in the changes in cortical thickness at any level of the femur. In conclusion, our study did not find evidence of cortical thickening at the ST/FS area of the femur with long‐term BP use. © 2014 American Society for Bone and Mineral Research.</description><identifier>ISSN: 0884-0431</identifier><identifier>EISSN: 1523-4681</identifier><identifier>DOI: 10.1002/jbmr.2345</identifier><identifier>PMID: 25156261</identifier><identifier>CODEN: JBMREJ</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Aged ; Aged, 80 and over ; ATYPICAL FEMORAL FRACTURE ; Biomarkers - metabolism ; BISPHOSPHONATE ; Bone Remodeling - drug effects ; CASE‐CONTROL STUDY ; CORTICAL THICKNESS ; Diphosphonates - pharmacology ; Female ; Femur - diagnostic imaging ; Femur - drug effects ; Humans ; Longitudinal Studies ; Male ; Middle Aged ; OSTEOPOROSIS ; Radiography ; Time Factors</subject><ispartof>Journal of bone and mineral research, 2015-02, Vol.30 (2), p.225-231</ispartof><rights>2014 American Society for Bone and Mineral Research</rights><rights>2014 American Society for Bone and Mineral Research.</rights><rights>2015 American Society for Bone and Mineral Research</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4875-3e7ee03831e4ebd036f959ca911587c8363ec11df8e0b1dbaafff69d67e8ba23</citedby><cites>FETCH-LOGICAL-c4875-3e7ee03831e4ebd036f959ca911587c8363ec11df8e0b1dbaafff69d67e8ba23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25156261$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Niimi, Rui</creatorcontrib><creatorcontrib>Kono, Toshibumi</creatorcontrib><creatorcontrib>Nishihara, Atsushi</creatorcontrib><creatorcontrib>Hasegawa, Masahiro</creatorcontrib><creatorcontrib>Matsumine, Akihiko</creatorcontrib><creatorcontrib>Kono, Toshihiko</creatorcontrib><creatorcontrib>Sudo, Akihiro</creatorcontrib><title>Cortical Thickness of the Femur and Long‐Term Bisphosphonate Use</title><title>Journal of bone and mineral research</title><addtitle>J Bone Miner Res</addtitle><description>ABSTRACT Femoral cortical thickening has been mentioned in reports of atypical subtrochanteric/femoral shaft (ST/FS) fractures, which are associated with long‐term bisphosphonate (BP) use. However, whether thickening precedes BP use or results from BP use, as well as the role BPs may play in cortical thickening remain unclear. The purpose of this study was to investigate the relationship between cortical thickness and BP use. We enrolled 142 patients (mean age 79 years) who had taken BPs for more than 5 years, and enrolled 426 osteoporosis patients who had not used BPs as controls. We performed a case‐control study of patients with long‐term BP use and controls matched for age, sex, and levels of activities of daily living (ADLs) (1:3 ratio). On femoral radiographs, we measured femoral cortical thickness in three regions: 5 cm and 12.5 cm below the lesser trochanter and in the region of maximal cortical thickness. We compared cortical thicknesses between patients taking BP and controls and evaluated longitudinal changes in cortical thickness. There were no significant differences in cortical thickness between long‐term BP users and controls. In addition, after further use of BP for a minimum of 1 year, we observed no significant differences in the changes in cortical thickness at any level of the femur. In conclusion, our study did not find evidence of cortical thickening at the ST/FS area of the femur with long‐term BP use. © 2014 American Society for Bone and Mineral Research.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>ATYPICAL FEMORAL FRACTURE</subject><subject>Biomarkers - metabolism</subject><subject>BISPHOSPHONATE</subject><subject>Bone Remodeling - drug effects</subject><subject>CASE‐CONTROL STUDY</subject><subject>CORTICAL THICKNESS</subject><subject>Diphosphonates - pharmacology</subject><subject>Female</subject><subject>Femur - diagnostic imaging</subject><subject>Femur - drug effects</subject><subject>Humans</subject><subject>Longitudinal Studies</subject><subject>Male</subject><subject>Middle Aged</subject><subject>OSTEOPOROSIS</subject><subject>Radiography</subject><subject>Time Factors</subject><issn>0884-0431</issn><issn>1523-4681</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNqF0b1OwzAUBWALgWgpDLwAssQCQ1o7jh1npBXlR0VIKMyRk1zTlCQudiPUjUfgGXkSEloYkBCDdZdP5-r6IHRMyZAS4o8WaWWHPgv4DupT7jMvEJLuoj6RMvBIwGgPHTi3IIQILsQ-6vmccuEL2kfjibGrIlMljudF9lyDc9hovJoDnkLVWKzqHM9M_fTx9h6DrfC4cMu56V6tVoAfHRyiPa1KB0fbOUDx9DKeXHuz-6ubycXMywIZco9BCECYZBQCSHPChI54lKmIUi7DTDLBIKM01xJISvNUKa21iHIRgkyVzwbobBO7tOalAbdKqsJlUJaqBtO4hEoiBSc84v9Twf1A0KhdOUCnv-jCNLZu72hVEPqR5FK26nyjMmucs6CTpS0qZdcJJUlXQdJVkHQVtPZkm9ikFeQ_8vvPWzDagNeihPXfScnt-O7hK_ITlDqP1g</recordid><startdate>201502</startdate><enddate>201502</enddate><creator>Niimi, Rui</creator><creator>Kono, Toshibumi</creator><creator>Nishihara, Atsushi</creator><creator>Hasegawa, Masahiro</creator><creator>Matsumine, Akihiko</creator><creator>Kono, Toshihiko</creator><creator>Sudo, Akihiro</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TS</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201502</creationdate><title>Cortical Thickness of the Femur and Long‐Term Bisphosphonate Use</title><author>Niimi, Rui ; Kono, Toshibumi ; Nishihara, Atsushi ; Hasegawa, Masahiro ; Matsumine, Akihiko ; Kono, Toshihiko ; Sudo, Akihiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4875-3e7ee03831e4ebd036f959ca911587c8363ec11df8e0b1dbaafff69d67e8ba23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>ATYPICAL FEMORAL FRACTURE</topic><topic>Biomarkers - metabolism</topic><topic>BISPHOSPHONATE</topic><topic>Bone Remodeling - drug effects</topic><topic>CASE‐CONTROL STUDY</topic><topic>CORTICAL THICKNESS</topic><topic>Diphosphonates - pharmacology</topic><topic>Female</topic><topic>Femur - diagnostic imaging</topic><topic>Femur - drug effects</topic><topic>Humans</topic><topic>Longitudinal Studies</topic><topic>Male</topic><topic>Middle Aged</topic><topic>OSTEOPOROSIS</topic><topic>Radiography</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Niimi, Rui</creatorcontrib><creatorcontrib>Kono, Toshibumi</creatorcontrib><creatorcontrib>Nishihara, Atsushi</creatorcontrib><creatorcontrib>Hasegawa, Masahiro</creatorcontrib><creatorcontrib>Matsumine, Akihiko</creatorcontrib><creatorcontrib>Kono, Toshihiko</creatorcontrib><creatorcontrib>Sudo, Akihiro</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Physical Education Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of bone and mineral research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Niimi, Rui</au><au>Kono, Toshibumi</au><au>Nishihara, Atsushi</au><au>Hasegawa, Masahiro</au><au>Matsumine, Akihiko</au><au>Kono, Toshihiko</au><au>Sudo, Akihiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cortical Thickness of the Femur and Long‐Term Bisphosphonate Use</atitle><jtitle>Journal of bone and mineral research</jtitle><addtitle>J Bone Miner Res</addtitle><date>2015-02</date><risdate>2015</risdate><volume>30</volume><issue>2</issue><spage>225</spage><epage>231</epage><pages>225-231</pages><issn>0884-0431</issn><eissn>1523-4681</eissn><coden>JBMREJ</coden><abstract>ABSTRACT Femoral cortical thickening has been mentioned in reports of atypical subtrochanteric/femoral shaft (ST/FS) fractures, which are associated with long‐term bisphosphonate (BP) use. However, whether thickening precedes BP use or results from BP use, as well as the role BPs may play in cortical thickening remain unclear. The purpose of this study was to investigate the relationship between cortical thickness and BP use. We enrolled 142 patients (mean age 79 years) who had taken BPs for more than 5 years, and enrolled 426 osteoporosis patients who had not used BPs as controls. We performed a case‐control study of patients with long‐term BP use and controls matched for age, sex, and levels of activities of daily living (ADLs) (1:3 ratio). On femoral radiographs, we measured femoral cortical thickness in three regions: 5 cm and 12.5 cm below the lesser trochanter and in the region of maximal cortical thickness. We compared cortical thicknesses between patients taking BP and controls and evaluated longitudinal changes in cortical thickness. There were no significant differences in cortical thickness between long‐term BP users and controls. In addition, after further use of BP for a minimum of 1 year, we observed no significant differences in the changes in cortical thickness at any level of the femur. In conclusion, our study did not find evidence of cortical thickening at the ST/FS area of the femur with long‐term BP use. © 2014 American Society for Bone and Mineral Research.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>25156261</pmid><doi>10.1002/jbmr.2345</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0884-0431
ispartof Journal of bone and mineral research, 2015-02, Vol.30 (2), p.225-231
issn 0884-0431
1523-4681
language eng
recordid cdi_proquest_miscellaneous_1808650595
source Oxford Journals Online
subjects Aged
Aged, 80 and over
ATYPICAL FEMORAL FRACTURE
Biomarkers - metabolism
BISPHOSPHONATE
Bone Remodeling - drug effects
CASE‐CONTROL STUDY
CORTICAL THICKNESS
Diphosphonates - pharmacology
Female
Femur - diagnostic imaging
Femur - drug effects
Humans
Longitudinal Studies
Male
Middle Aged
OSTEOPOROSIS
Radiography
Time Factors
title Cortical Thickness of the Femur and Long‐Term Bisphosphonate Use
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-23T16%3A11%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cortical%20Thickness%20of%20the%20Femur%20and%20Long%E2%80%90Term%20Bisphosphonate%20Use&rft.jtitle=Journal%20of%20bone%20and%20mineral%20research&rft.au=Niimi,%20Rui&rft.date=2015-02&rft.volume=30&rft.issue=2&rft.spage=225&rft.epage=231&rft.pages=225-231&rft.issn=0884-0431&rft.eissn=1523-4681&rft.coden=JBMREJ&rft_id=info:doi/10.1002/jbmr.2345&rft_dat=%3Cproquest_cross%3E1652461936%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4875-3e7ee03831e4ebd036f959ca911587c8363ec11df8e0b1dbaafff69d67e8ba23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1647298588&rft_id=info:pmid/25156261&rfr_iscdi=true